MSAC consultation process - changes to take effect from 1 July 2021

16 June 2021 - MSAC is implementing changes to its consultation process from 1 July 2021.  ...

Read more →

MSAC Technical Guidelines - release of guidelines for preparing assessments for the Medical Services Advisory Committee (Version 1.0, May 2021)

16 June 2021 - The Department of Health is pleased to announce the publication of the Guidelines for Preparing Assessments ...

Read more →

Core patient reported outcomes in cancer clinical trials

9 June 2021 - This guidance provides recommendations to sponsors for collection of a core set of patient reported clinical outcomes ...

Read more →

Updated financial estimates workbook

10 June 2021 - An updated version of the Utilisation and Cost Model workbook and User Manual is now available to ...

Read more →

FDA announces draft guidances to help increase transparency, assist reporting and timely completion for certain medical device studies after FDA approval or clearance

26 May 2021 - Today, the U.S. FDA issued two guidances regarding the surveillance of certain medical devices. ...

Read more →

Adjusting for covariates in randomised clinical trials for drugs and biological products

20 May 2021 - This guidance represents FDA’s current thinking on adjusting for covariates in the statistical analysis of randomised clinical ...

Read more →

New recommendations on the critical appraisal of systematic reviews with cost and cost effectiveness outcomes

13 April 2021 - ISPOR announced today the publication of new guidance on how to evaluate the quality and risk ...

Read more →

NICE publishes single guideline for managing COVID-19

23 March 2021 - One year on from the first national lockdown, NICE has today published a single guideline for the ...

Read more →

Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers

25 February 2021 - EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in ...

Read more →

Modifying NICE’s approach to equity weighting

7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...

Read more →

NICE’s discounting review: clear thinking on rational revision meets obstacle of industrial interests

7 February 2021 - NICE recently published a review of discounting practice and theory as part of a consultation on ...

Read more →

NICE’s processes of technology evaluation - presenting a case for change

4 February 2021 - NICE has today launched a public consultation on proposals for changes to the processes it uses to ...

Read more →

New toolbox available for EMA's PRIME designees

2 February 2021 - The European Medicines Agency has released a draft guidance to assist drug developers using its Priority ...

Read more →

Qualitative comparative analysis of health economic evaluation guidelines for health technology assessment in European countries

10 December 2020 - Zisis and colleagues performed a literature review to identify published guidance for the conduct and assessment ...

Read more →

FDA offers guidance to enhance diversity in clinical trials, encourage inclusivity in medical product development

9 November 2020 - To further promote and protect public health, it is important that people who are in clinical trials ...

Read more →